Navigation Links
Celling Technologies Sets New Standards With Sophisticated Adult Stem Cell Device
Date:8/21/2009

sults," said Dr. Johnson.

Dr. Johnson worked closely with the team from Celling and ThermoGenesis to evaluate the clinical applications of the MXP System and will continue working to further develop its capabilities. Celling believes the MXP system provides high yields of cell concentration, a closed system that minimizes the risk for contamination and data collection capabilities for clinical research and patient reporting.

Celling Technologies is currently developing stem cell therapy in general orthopedics, cardiovascular, plastic surgery and trauma. Close collaboration with key surgeons will help define the scope of opportunity for cell therapy. Celling's current objective for stem cell therapy is to define the standard of care through clinical performance and potentially lower healthcare costs by offering different means of preventative medicine.

About Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine. Celling's product offering focuses on autologous adult stem cell therapy and the devices and services that complement these procedures.

About Neurosurgical Associates of San Antonio

Neurosurgical Associates of San Antonio provides comprehensive spine care across a full spectrum of neurologic and spinal surgery. Neurosurgical Associates of San Antonio is committed to providing state-of-the-art neurosurgical and spine care as well as the highest quality of care, compassion and excellence to patients.

About ThermoGenesis Corporation

ThermoGenesis Corp. (Nasdaq: KOOL) is a leader in developing and manufacturing automate
'/>"/>

SOURCE Celling Technologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. VirtualHealth Technologies Files 8k Related to the August 17th Announcement of Private Access Payment and Document Modification
2. Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence
3. EF Johnson Technologies, Inc. Highlights New Products at APCO 2009
4. Global Med Technologies(R) Announces Second Quarter and First Half Results
5. AirStrip Technologies Releases AirStrip OB for BlackBerry
6. Wound Management Technologies Reaches Agreement in Principle for Exclusive Distribution of CellerateRx(R) Products in Italy
7. China Medical Technologies Announces Change of Independent Auditors
8. CIBER Completes Commercial Software Redesign; Awarded New Contract From TeleTracking Technologies
9. Patient Safety Technologies Reports Second Quarter Results
10. Greenway Medical Technologies EHR Solution, PrimeSuite, Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Sciences, a 2009 CMS Qualified PQRI Registry
11. China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Dennis Thompson HealthDay Reporter ... combination of therapy and antidepressants appears to best help ... reports. Four out of five people suffering from ... recovery when treated with cognitive therapy plus antidepressant medication, ... didn,t work much better than drugs alone in helping ...
(Date:8/21/2014)... 2014 Seattle, WA chiropractors Dr. ... Eastlake Chiropractic and Massage Center have recently welcomed ... Rina Lang, LMP and Mike Larios, LMP have ... massage techniques, and have developed their expertise working in ... particularly important in a clinical environment where massage is ...
(Date:8/21/2014)... August 21, 2014 The results of ... in The Journal of the American Medical Association (JAMA) ... cancers and reduces unnecessary recalls. Memorial Healthcare System was ... study. , “This study confirms what we already know ... cancers we want to find and, at the same ...
(Date:8/21/2014)... The second bellwether trial involving ... has begun in Massachusetts state court. The device ... Law Group LLP, a national personal injury law ... stemming from the implantation of mesh products, provides ... injuries suffered at http://www.wehelpwomen.com/transvaginal-mesh/ . , Maria ...
(Date:8/21/2014)... The Swedish-American Life Science Summit, (SALSS) ... on the Future of Medicine and the challenges ... , With the mission to turn new sciences ... business and science. "Over the years SALSS has ... diverse community with representatives challenging the boundaries of ...
Breaking Medicine News(10 mins):Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2Health News:Transvaginal Mesh Lawsuit News: Second Boston Scientific Mesh Bellwether Trial Begins, The Rottenstein Law Group LLP Reports 2Health News:The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine 2
... , , , ... DST Health Solutions, a leading provider of software and services ... certification, a designation demonstrating its commitment to quality product development. ... Registrar, an independent auditing firm, for meeting the guidelines set ...
... LEBANON, Tenn., July 28 Health Connect Partners, Inc. ( ... the title sponsor of its 2009 Fall Hospital Pharmacy Conference. ... up to 200 directors of pharmacy from some of the largest ... sessions led by healthcare industry experts, the Hospital Pharmacy Conference will ...
... COLORADO SPRINGS, Colo., July 28 Now that summer is in ... across the county. , , With millions enjoying their ... for home pool and hot tub safety is urgent. , , ... home pool and hot tub owners to make safety their priority by following ...
... , WILTON, Conn., July 28, ... Friday, July 24 and Saturday, July 25 in Chicago, Eucerin was ... incidental sun exposure and give them a glimpse into their skin,s ... year marked Eucerin,s first appearance at the annual BlogHer Conference, connecting ...
... , CHICAGO, July 28 When at the pool ... the harmful rays of the sun. But do we remember to apply sunscreen to ... on the feet from unprotected sun exposure, and overlook applying sunscreen to the area. ... of the foot is prevalent and can even be fatal if not caught early. ...
... Mylan Inc. (Nasdaq: MYL ) today reported that in ... proactively and as a courtesy had contacted the U.S. Food and ... a recent news article. As a result, the FDA visited the ... the baseless accusations in the article were unfounded. The FDA noted ...
Cached Medicine News:Health News:DST Health Solutions Achieves ISO 9001:2008 Certification 2Health News:Cardinal Health Announced as Title Sponsor of the Health Connect Partners' 2009 Fall Hospital Pharmacy Conference 2Health News:Seven Tips for Safer Home Swimming Pools and Hot Tubs 2Health News:Eucerin Provides BlogHer Attendees With a Glimpse Into Their Skin's Future With Proprietary 'Time Machine' Aging Simulator 2Health News:Sunscreen on Your Feet? Doctors Urge Sunscreen Use and Exams to Prevent Skin Cancer on Feet 2Health News:Mylan Reports That the FDA Determined That All Accusations Were Unfounded 2
(Date:8/21/2014)... SAN JOSE, Calif. , Aug. 21, 2014 /PRNewswire/ ... a medical device company that pioneered the use of ... surgical (MIS) device indicated for fusion of the sacroiliac ... ) published an update to its Lumbar Fusion ... MIS SI joint fusion procedure.  The policy states that ...
(Date:8/21/2014)... , Aug. 21, 2014   Auxilium ... a specialty biopharmaceutical company, today announced positive results ... collagenase clostridium histolyticum (or CCH) for the treatment ... cellulite. In the Phase 2a trial, all three ... high (0.84mg)) showed an improvement in the appearance ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
Breaking Medicine Technology:SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... candidate, has been granted orphan drug designation from the ... of pediatric Clostridium difficile infection (CDI).  This ... covers all formulations of fidaxomicin used to treat ...
... 2011 ULURU Inc. (NYSE Amex: ULU), ... a portfolio of wound management and oral care products, today ... 5,000,000 shares of its common stock at a price per ... an institutional investor, resulting in gross proceeds of approximately $500,000. ...
Cached Medicine Technology:Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 2Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 3Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 4ULURU Inc. to Raise $500,000 in Registered Direct Offering 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: